| Date Filed | Type | Description |
| 10/12/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 09/28/2023 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $45.1268, valued at
$451.3k
|
|
| 09/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Exercised 1,777 restricted stock units
@ $0
Exercised 5,333 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 10,321 options to buy
@ $41.08, valued at
$424k
Granted 4,677 restricted stock units
@ $0 |
|
| 05/18/2023 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $37.89, valued at
$378.9k
|
|
| 09/09/2022 |
3/A
| PARSHALL B LYNNE (Director) has filed a Form 3/A on Foghorn Therapeutics Inc. |
| 09/01/2022 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Sold 30,296 shares
@ $52.79, valued at
$1.6M
Exercised 5,714 options to buy
@ $8.75, valued at
$50k
Exercised 20,000 options to buy
@ $9.45, valued at
$189k
Exercised 4,582 options to buy
@ $6.82, valued at
$31.2k
|
|
| 08/18/2022 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 32,000 options to buy
@ $16.34, valued at
$522.9k
|
|
| 08/18/2022 |
3
| PARSHALL B LYNNE (Director) has filed a Form 3 on Foghorn Therapeutics Inc. |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,652 shares
@ $30.12, valued at
$49.8k
Exercised 5,754 restricted stock units
@ $0 |
|
| 11/05/2021 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Sold 20,000 shares
@ $40, valued at
$800k
Sold 4,032 shares
@ $40, valued at
$161.3k
Sold 4,166 shares
@ $40, valued at
$166.6k
Sold 2,798 shares
@ $40, valued at
$111.9k
Exercised 4,166 options to buy
@ $6.78, valued at
$28.2k
Exercised 2,798 options to buy
@ $6.84, valued at
$19.1k
Exercised 4,032 options to buy
@ $12.4, valued at
$50k
Exercised 20,000 options to buy
@ $14.25, valued at
$285k
|
|
| 10/20/2021 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Sold 1,999 shares
@ $35.7343, valued at
$71.4k
Sold 8,333 shares
@ $35.7343, valued at
$297.8k
Exercised 8,333 options to buy
@ $6.6, valued at
$55k
Exercised 1,999 options to buy
@ $6.84, valued at
$13.7k
|
|
| 07/19/2021 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Exercised 5,333 restricted stock units
@ $0
Exercised 889 restricted stock units
@ $0
Exercised 1,778 restricted stock units
@ $0 |
|
| 07/06/2021 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 12,000 options to buy
@ $40.05, valued at
$480.6k
Granted 5,333 restricted stock units
@ $0 |
|
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 2,741 shares
@ $61.28, valued at
$168k
Exercised 10,655 restricted stock units
@ $0 |
|
| 12/28/2020 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $60, valued at
$600k
|
|
| 11/30/2020 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 3,590 shares
@ $50.05, valued at
$179.7k
Exercised 3,590 options to buy
@ $39.87, valued at
$143.1k
|
|
| 11/25/2020 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 3,200 shares
@ $50.12, valued at
$160.4k
Sold 710 shares
@ $50.82, valued at
$36.1k
Exercised 3,200 options to buy
@ $39.87, valued at
$127.6k
Exercised 710 options to buy
@ $39.87, valued at
$28.3k
|
|
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2020 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 26,400 options to buy
@ $16.14, valued at
$426.1k
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2020 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 3,905 shares
@ $62.06, valued at
$242.3k
Exercised 15,136 restricted stock units
@ $0 |
|
| 07/03/2019 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Exercised 889 restricted stock units
@ $0
Granted 7,110 restricted stock units
@ $0
Granted 16,000 options to buy
@ $64.8, valued at
$1M
|
|
| 06/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2019 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on CYTOKINETICS INC|
Txns:
| Granted 20,000 options to buy
@ $10.68, valued at
$213.6k
|
|
|